Sydney, Australia
Associate Professor in Vascular Surgery
The University Of New South Wales
Vascular Surgeon
Prince of Wales Hospital
SCHEDULE FOR VEITHsymposium™
Wednesday, November 17, 2021
Presenter
SESSION 24: NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE)
What Is The Future For Bioresorbable DESs To Treat BTK Lesions: Good Long-Term Results Including The DISAPPEAR Trial Justify A New Trial: The LIFE-BTK Trial With The Esprit Stent From Abbott
8:04 AM - 8:09 AM

View Slides in PDF
Presenter
SESSION 25: LOWER EXTREMITY TOPICS RELATED TO THE DRUG COATED DEVICES CAUSING INCREASED MORTALITY CONTROVERSY: DO PACLITAXEL COATED DEVICES CAUSE INCREASED MORTALITY (5 AND 4 ¾-MINUTE SHORT SUMMARY [SS] TALKS)
Mortality Rates After Paclitaxel Coated Device Use In Patients With Both Critical Limb Ischemia (CLI) And Claudication: Two Systematic Reviews And Meta-Analyses Of Randomized Controlled Trials Show NO Increased Mortality With Paclitaxel Coated Devices Up To 5 Years
8:40 AM - 8:45 AM

View Slides in PDF
Thursday, November 18, 2021
Presenter
SESSION 56: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, TACKS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
Value of New Dedicated Special Tools And Devices To Facilitate Trans-Radial Access For Lower Extremity Lesion Treatments: How Far Distally Can It Be Effective
2:24 PM - 2:29 PM

View Slides in PDF
 
previous next